 Wysłany: Pon 15:43, 07 Mar 2011 Temat postu: ghd italia ddv uvl tez dom |
|
| High sensitivity C-reactive protein and serum lipids in acute coronary syndrome joint detection and correlation in
gJE, CookNR, eta1. C-reactiveprotein, themeta a [15] [16] [17] [I8】 [19] [2O] [21] [22] [23] [24] bolicsyndrome, andriskofincidenteardiovaseularevents: an8-yearfollow-upofl4719initiallyhealthyAmericanwomen [J]. Circula-tion, 2o06, 1o7 (3) :391-397. Tu Hai Jian, XIE Zhi, Lin, et al. Sensitivity C-reactive protein in acute coronary syndrome in the sense [J]. Laboratory Medicine and Clinical, 2007,4 (12) :1145-1147. RifaiN, RidkerPM. proposedcardiovascularriskassessmentalgo-rithmusinghighsensitivityC-reactiveproteinandlipidscreening [J]. ClinChen, 2008,ghd italia,47 (1) :28-3O. Ge Qingwei. High sensitivity C reactive protein in neonatal infections application [J]. Shanghai Medical Laboratory Technology, 2002,4 (1) :211-212. Shi Hong Yan, Ma Rong, Zhao Chengyan, et al. Sensitivity c-reactive protein and serum lipids of a combined detection of coronary artery disease [J]. Dalian Medical University, 2007,29 (6) :591-593. Jean Lee. Sensitivity C-reactive protein in cardiovascular disease and its clinical significance [J]. Cardiovascular Diseases, 2007,28 (1) :92-96, KullerLH, TraeyRP, ShatenJ, eta1. RelationofC-reactiveproteinandcoronaryheartdiseaseintheMRFITnestedcase-controlstudy. MultipleRiskFactorInterventionTrial [J]. AmJEpidemic, l2007, 144 (2) :537-547. ShahSH. NewbyLK. C-reactiveprotein: Anovelmarkerofcardiovas-cularrisk [J]. CardiolRev,tory burch flats, 2006,11 (4) :169-179. PaulMR. ChristopherPC. DavidM. eta1. C-reactiveproteinlevelsandoutcomesafterstatintherapy [J]. NEnglJMed, 2008,adidas scarpe,352 (6): 2O a 28. Tu Hai Jian, XIE Zhi, Lin, et al. High sensitivity C reactive protein in acute coronary syndrome in the sense [J]. Laboratory Medicine and Clinical, 2007,tory burch reva,4 (12) :1145-1146. DaneshJ, WheelerJG, HirschficldGM, eta1. C-reactiveproteinandothercirculatingmarkersofinflammationinthepredictionofcoro-naryheartdisease [J]. NEnglJMed, 2007,350 (3) :1387-1397. Pylori (Hp) in peptic ulcer occurred in the understanding of the role, so that nearly 20 years, the diagnosis of peptic ulcer disease, treatment has undergone tremendous change. In particular the PPI and the eradication of Helicobacter pylori in peptic ulcer therapy, reducing the incidence of peptic ulcer, and the incidence of various complications, the patient's quality of life greatly improved. In this paper,mbt scarpe, peptic ulcer disease etiology and pathogenesis, clinical treatment and prevention of ulcer recurrence and reviewed. An etiology, pathogenesis and treatment of peptic ulcer disease is caused by various factors, the incidence of peptic ulcer is usually considered a result of damage to gastric mucosa imbalance between factors and protective factors. When the factors of gastric damage than defense factors, ulcer may form, in addition to fine |
|
